Literature DB >> 15158367

In vivo trafficking of endothelial progenitor cells their possible involvement in the tumor neovascularization.

Michie Tamura1, Keiko Unno, Sei Yonezawa, Kenji Hattori, Emi Nakashima, Hideo Tsukada, Motowo Nakajima, Naoto Oku.   

Abstract

Circulating endothelial progenitor cell (EPCs) have been reported to contribute to vasculogenesis in adult organisms. To investigate the possible recruitment of EPCs and organization to form tumor vasculature, we investigated the in vivo real-time trafficking of EPCs non-invasively by using positron emission tomography (PET). A conditionally immortalized endothelial cell line derived from rat bone marrow (TR-BME1) was labeled with [2-(18)F] 2-fluoro-2-deoxy-D-glucose (FDG) and chased the accumulation in the rat tumor with PET. TR-BME1 cells were accumulated in the tumor tissues time-dependently. To investigate that the accumulation of the cells is specific or not, rats were previously irradiated with gamma-ray to suppress the influence of non-labeled EPCs derived from its bone marrow and used for PET analysis. The accumulation of TR-BME1 cells in the tumor was enhanced in gamma-ray-irradiated rats compared with that of non-irradiated ones, suggesting that TR-BME1 cells accumulated in the tumor specifically like as EPCs. Then the involvement of matrix metalloproteinases (MMPs) in EPC recruitment was examined. An inhibitor of MMP, MMI270, which suppressed invasion and tube formation abilities of TR-BME1 cells, only slightly suppressed the accumulation of TR-BME1 cells in the tumor of rats. These results suggest that EPCs are recruited in the tumor tissues for formation of tumor vasculature, and demonstrate the usefulness of TR-BME1 cells for studies on EPC related phenomena.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158367     DOI: 10.1016/j.lfs.2003.12.025

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  SPECT and PET to optimize cardiac stem cell therapy.

Authors:  Angel T Chan; M Roselle Abraham
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

Review 2.  Stem Cell Monitoring with a Direct or Indirect Labeling Method.

Authors:  Min Hwan Kim; Yong Jin Lee; Joo Hyun Kang
Journal:  Nucl Med Mol Imaging       Date:  2015-10-22

Review 3.  Non-invasive cell tracking in cancer and cancer therapy.

Authors:  Hao Hong; Yunan Yang; Yin Zhang; Weibo Cai
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

Review 4.  Gene therapy imaging in patients for oncological applications.

Authors:  Iván Peñuelas; Uwe Haberkorn; Shahriar Yaghoubi; Sanjiv S Gambhir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

5.  Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice.

Authors:  Takuji Torimura; Takato Ueno; Eitaro Taniguchi; Hiroshi Masuda; Hideki Iwamoto; Toru Nakamura; Kinya Inoue; Osamu Hashimoto; Mitsuhiko Abe; Hironori Koga; Vincenza Barresi; Emi Nakashima; Hirohisa Yano; Michio Sata
Journal:  Cancer Sci       Date:  2012-01-25       Impact factor: 6.716

Review 6.  Endothelial precursor cells.

Authors:  May J Reed; Nathan Karres; Daniel Eyman; Jay Edelberg
Journal:  Stem Cell Rev       Date:  2007       Impact factor: 6.692

7.  Non-invasive imaging of endothelial progenitor cells in tumor neovascularization using a novel dual-modality paramagnetic/near-infrared fluorescence probe.

Authors:  Xin-Yi Wang; Shenghong Ju; Cong Li; Xin-Gui Peng; Alex F Chen; Hui Mao; Gao-Jun Teng
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

8.  Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy.

Authors:  A Z Dudek; V Bodempudi; B W Welsh; P Jasinski; R J Griffin; L Milbauer; R P Hebbel
Journal:  Br J Cancer       Date:  2007-07-24       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.